Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to sign an informed consent form agreeing to take part in the trial
- People who are 18 years of age or older
- People who have glaucoma, are scheduled for a trabeculectomy (a type of eye surgery for glaucoma), are scheduled to receive an ocriplasmin injection (a treatment for certain eye conditions), or are healthy volunteers
Who may not be able to join:
- People who have previously had a vitrectomy (a type of eye surgery where the gel inside the eye is removed)
- People who have diabetes
- People who have a history of Retinal Vessel Occlusion (a blockage of the blood vessels in the retina at the back of the eye)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ingeborg Stalmans, MD PhD, Dpt. Ophthalmology, University Hospitals Leuven, Belgium
Phone: 016 33 23 70
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Prevalence of VPT in glaucoma patients; Change in VPT following trabeculectomy; Change in VPT following ocriplasmin
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.